Drug companies face COVID cliff in 2023 as sales set to plummet
- ByReuters-
By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments...